C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1997
10/09/1997	CA2250834A1 Cultured inner cell mass cell lines derived from ungulate embryos
10/09/1997	CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	CA2250702A1 Active survival domains of igf-ir and methods of use
10/09/1997	CA2250394A1 Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
10/09/1997	CA2250129A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997	CA2250121A1 Tfiib transcription factor from candida albicans
10/09/1997	CA2250111A1 Single-step excision means
10/09/1997	CA2250110A1 Growth differentiation factor-14
10/09/1997	CA2250041A1 Parapoxvirus vectors
10/09/1997	CA2249990A1 Antifungal polypeptide and methods for controlling plant pathogenic fungi
10/09/1997	CA2249349A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/09/1997	CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997	CA2248615A1 Monoclonal antibody that detects apoptotic antigen
10/09/1997	CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997	EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/08/1997	EP0799317A1 Method for secreting thrombopoietin polypeptides
10/08/1997	EP0799316A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups
10/08/1997	EP0799315A2 Telomerase protein component
10/08/1997	EP0799313A2 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
10/08/1997	EP0799311A1 Human chemokine beta-9
10/08/1997	EP0799310A1 Production of recombinant secretory component
10/08/1997	EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997	EP0799305A1 Transgenic animal lacking native amyloid precursor protein
10/08/1997	EP0799049A1 COSMETIC OR PHARMACEUTICAL AND PARTICULARLY DERMATOLOGICAL COMPOSITION, AND CULTURE MEDIUM CONTAINING A $i(SMELOPHYLLUM CAPENSE) EXTRACT
10/08/1997	EP0798958A1 Genetically modified plants having modulated flower development
10/08/1997	CN1161744A In vitro models of CNS function and dysfunction
10/08/1997	CN1161717A Control of plant gene expression
10/08/1997	CN1161714A Human chemokine beta-9
10/07/1997	US5675063 Immortalized rabbit hybridoma fusion partner
10/07/1997	US5675061 Isolation and characterization of an actin gene from abalone
10/07/1997	US5675060 Expression of transgene results in mouse having chronic inflammation and deformation of synovial joints; for determining antiarthritic potentials of compositions
10/07/1997	US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997	US5674984 Method for isolation of unclipped HIV envelope protein
10/07/1997	US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997	US5674908 Macromolecule/lipid aggregates; drug delivery
10/07/1997	US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997	US5674848 Bioreactor compositions with enhanced cell binding
10/07/1997	US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997	US5674750 Continuous selective clonogenic expansion of relatively undifferentiated cells
10/07/1997	US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
10/07/1997	US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same
10/07/1997	US5674734 Cell death protein
10/07/1997	US5674731 An auxin plant growth intensifiers
10/07/1997	US5674723 Nucleic acid obtained from ribonuclease and proteinase treated mitochondria-free cytoplasmic fraction isolated from permanently culturable cells
10/07/1997	US5674722 Genetic modification of endothelial cells
10/07/1997	US5674719 Method for producing monoclonal antibodies specific to hair follicles
10/07/1997	US5674710 Recombinant techniques for production of human brain natriuretic peptide
10/07/1997	US5674701 Administering an inhibitory amount of ethylene; screening for ethylene insensitivity; inoculating with pathogen; screening for disease tolerance
10/07/1997	US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997	US5674499 Equine herpesvirus gene 15 mutants
10/07/1997	US5674484 Vaccine antigens for treatment of poultry
10/07/1997	CA1339489C Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
10/07/1997	CA1339488C De-n-acetyl-syalic acid and their applications as modifiers of cell physiology
10/02/1997	WO1997036004A1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
10/02/1997	WO1997035999A2 Production of vanillin
10/02/1997	WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997	WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997	WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	WO1997035986A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
10/02/1997	WO1997035983A2 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm
10/02/1997	WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997	WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997	WO1997035977A1 Polycation-sensing receptor in aquatic species and methods of use thereof
10/02/1997	WO1997035976A2 Epidermal differentiation factor
10/02/1997	WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997	WO1997035972A1 Recombinant nucleic acid sequences coding for proteins with at least one hydrophobic domain, and uses thereof
10/02/1997	WO1997035966A1 Methods and compositions for cellular and metabolic engineering
10/02/1997	WO1997035965A1 Plant sugar sensors and uses thereof
10/02/1997	WO1997035960A1 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
10/02/1997	WO1997035958A1 Storage articles for prolonged viability and function of living cells
10/02/1997	WO1997035957A1 Evolving cellular dna uptake by recursive sequence recombination
10/02/1997	WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997	WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997	WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	WO1997035472A1 Use of arabinogalactan in cell cryopreservation media
10/02/1997	WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997	WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997	DE19612967A1 Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren Method for replication of influenza viruses in cell culture, as well as the influenza viruses obtainable by the process
10/02/1997	DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses
10/02/1997	DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997	CA2257120A1 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997	CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997	CA2250202A1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
10/02/1997	CA2250173A1 Cytochrome p450 transducing retroviral vectors
10/02/1997	CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	CA2250119A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
10/02/1997	CA2250099A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997	CA2250084A1 Use of arabinogalactan in cell cryopreservation media
10/02/1997	CA2250069A1 Polycation-sensing receptor in aquatic species and methods of use thereof
10/02/1997	CA2250058A1 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	CA2250043A1 Production of vanillin
10/02/1997	CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997	CA2249987A1 Packaging cell line based on human 293 cells
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249466A1 Recombinant nucleic acid sequences coding for proteins with at least one hydrophobic domain, and uses thereof

1 ... 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 ... 1827